annual FCF:
-$110.34M-$12.65M(-12.95%)Summary
- As of today (July 6, 2025), EWTX annual free cash flow is -$110.34 million, with the most recent change of -$12.65 million (-12.95%) on December 31, 2024.
- During the last 3 years, EWTX annual FCF has fallen by -$76.17 million (-222.87%).
- EWTX annual FCF is now -1079.98% below its all-time high of -$9.35 million, reached on December 31, 2019.
Performance
EWTX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$37.91M-$10.68M(-39.22%)Summary
- As of today (July 6, 2025), EWTX quarterly free cash flow is -$37.91 million, with the most recent change of -$10.68 million (-39.22%) on March 31, 2025.
- Over the past year, EWTX quarterly FCF has dropped by -$9.02 million (-31.20%).
- EWTX quarterly FCF is now -1279.55% below its all-time high of -$2.75 million, reached on March 31, 2020.
Performance
EWTX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$119.36M-$9.02M(-8.17%)Summary
- As of today (July 6, 2025), EWTX TTM free cash flow is -$119.36 million, with the most recent change of -$9.02 million (-8.17%) on March 31, 2025.
- Over the past year, EWTX TTM FCF has dropped by -$19.96 million (-20.08%).
- EWTX TTM FCF is now -4243.34% below its all-time high of -$2.75 million, reached on March 31, 2020.
Performance
EWTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
EWTX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.9% | -31.2% | -20.1% |
| 3 y3 years | -222.9% | -192.9% | -191.1% |
| 5 y5 years | -1080.0% | -1279.5% | -1624.5% |
EWTX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -222.9% | at low | -185.2% | at low | -148.9% | at low |
| 5 y | 5-year | -1080.0% | at low | -1056.5% | at low | -1624.5% | at low |
| alltime | all time | -1080.0% | at low | -1279.5% | at low | -4243.3% | at low |
EWTX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$37.91M(+39.2%) | -$119.36M(+8.2%) |
| Dec 2024 | -$110.34M(+12.9%) | -$27.23M(-2.4%) | -$110.34M(+0.2%) |
| Sep 2024 | - | -$27.89M(+6.0%) | -$110.10M(+5.1%) |
| Jun 2024 | - | -$26.32M(-8.9%) | -$104.72M(+5.4%) |
| Mar 2024 | - | -$28.89M(+7.1%) | -$99.39M(+1.7%) |
| Dec 2023 | -$97.69M(+67.9%) | -$26.99M(+19.9%) | -$97.69M(+13.8%) |
| Sep 2023 | - | -$22.52M(+7.3%) | -$85.85M(+12.0%) |
| Jun 2023 | - | -$20.99M(-22.8%) | -$76.63M(+5.8%) |
| Mar 2023 | - | -$27.19M(+79.5%) | -$72.43M(+24.5%) |
| Dec 2022 | -$58.18M | -$15.15M(+14.0%) | -$58.18M(+10.8%) |
| Sep 2022 | - | -$13.29M(-20.9%) | -$52.53M(+9.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$16.80M(+29.8%) | -$47.95M(+17.0%) |
| Mar 2022 | - | -$12.94M(+36.2%) | -$41.00M(+20.0%) |
| Dec 2021 | -$34.17M(+130.3%) | -$9.50M(+9.0%) | -$34.17M(+16.6%) |
| Sep 2021 | - | -$8.71M(-11.5%) | -$29.32M(+22.8%) |
| Jun 2021 | - | -$9.85M(+60.9%) | -$23.88M(+31.2%) |
| Mar 2021 | - | -$6.12M(+31.9%) | -$18.21M(+22.7%) |
| Dec 2020 | -$14.84M(+58.7%) | -$4.64M(+41.5%) | -$14.84M(+45.5%) |
| Sep 2020 | - | -$3.28M(-21.4%) | -$10.20M(+47.4%) |
| Jun 2020 | - | -$4.17M(+51.9%) | -$6.92M(+151.9%) |
| Mar 2020 | - | -$2.75M | -$2.75M |
| Dec 2019 | -$9.35M | - | - |
FAQ
- What is Edgewise Therapeutics annual free cash flow?
- What is the all time high annual FCF for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual FCF year-on-year change?
- What is Edgewise Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly FCF year-on-year change?
- What is Edgewise Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Edgewise Therapeutics?
- What is Edgewise Therapeutics TTM FCF year-on-year change?
What is Edgewise Therapeutics annual free cash flow?
The current annual FCF of EWTX is -$110.34M
What is the all time high annual FCF for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual free cash flow is -$9.35M
What is Edgewise Therapeutics annual FCF year-on-year change?
Over the past year, EWTX annual free cash flow has changed by -$12.65M (-12.95%)
What is Edgewise Therapeutics quarterly free cash flow?
The current quarterly FCF of EWTX is -$37.91M
What is the all time high quarterly FCF for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly free cash flow is -$2.75M
What is Edgewise Therapeutics quarterly FCF year-on-year change?
Over the past year, EWTX quarterly free cash flow has changed by -$9.02M (-31.20%)
What is Edgewise Therapeutics TTM free cash flow?
The current TTM FCF of EWTX is -$119.36M
What is the all time high TTM FCF for Edgewise Therapeutics?
Edgewise Therapeutics all-time high TTM free cash flow is -$2.75M
What is Edgewise Therapeutics TTM FCF year-on-year change?
Over the past year, EWTX TTM free cash flow has changed by -$19.96M (-20.08%)